Cinzia Emilia Lavarino

Cinzia Emilia Lavarino

Jefe de Grupo Senior

Research group

Translational Genomics

Cinzia Lavarino graduated in Biology in 1994 and obtained a Doctor of Biotechnology degree in 1999 from the Università degli Studi di Milano, Italy.

Between 1994 and 2001 she was trained at the Molecular Diagnostic Laboratory of the Instituto Nazionale dei Tumori in Milan.

Between 2001-2004 she completed a post-doctoral stay at the Department of Biochemistry, Faculty of Pharmacy, University of Barcelona.

In 2005, she joined the post-doctoral researcher at the Development Tumours Laboratory of the SJD Barcelona Children’s Hospital.

Since 2007 Cinzia Lavarino is Principal Investigator of the Translational Genomics group of the Laboratory of Developmental Tumours, included in the IRSJD Pediatric Cancer Program.

Since the beginning of 2019, Cinzia Lavarino has been a doctor in charge of healthcare activities (molecular diagnosis, prognosis prediction, molecular classification, identification of therapeutic targets, molecular monitoring of the disease) typical of the Molecular Oncology Laboratory of the Paediatric Cancer Center Barcelona (PCCB) of the SJD Barcelona Children's Hospital.

cinzia.lavarino@sjd.es

Professional network profiles

Last Publications

More Publications

Projects

Project name:
GLIOMATCH_The malignant Glioma immuno-oncology matchmaker: towards data-driven precision medicine using spatially resolved radio-multiomics
Leader
Andrés Morales La Madrid
Funding entities:
European Commission
Code
101136670
Starting - finishing date:
2024 - 2028
Project name:
Ensayo clínico de seguridad y factibilidad de inmunoterapia celular: Células dendríticas autólogas pulsadas con un lisado de líneas tumorales alogénicas, asociadas con CART anti-IL13Ra2 en pacientes con tumor difuso intrínseco de tronco (DIPG) (fase Ib)
Leader
Andrés Morales La Madrid
Funding entities:
Instituto de Salud Carlos III (ISCIII)
Code
ICI23/00063
Starting - finishing date:
2024 - 2027
Project name:
Multi-ómica y cribado masivo de fármacos para el tratamiento dirigido del Neuroblastoma resistente al tratamiento
Leader
Cinzia Emilia Lavarino , Marta García López
Funding entities:
Instituto de Salud Carlos III (ISCIII)
Code
PI23/00120
Starting - finishing date:
2024 - 2026
More projects

News

See All news